Mean ± SD of the different parameters relative to bipedal stance on soft support with the eyes open recorded in the Chewing and Hand Grip groups. by Cristina Dolciotti (16317330)

Subjects:

Time course of Path Length, LFS and Velocity during postural training. by Cristina Dolciotti (16317330)

Subjects:

Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. by Cristina Dolciotti (16317330)

Subjects:

Time course of 95% Area, X and Y Amplitude Sway during postural training. by Cristina Dolciotti (16317330)

Subjects:

Correlations between unipedal and bipedal stance parameters recorded at the beginning of the training and of the control session. by Cristina Dolciotti (16317330)

Subjects:

Flow diagram. by Cristina Dolciotti (16317330)

Subjects:

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

Sociodemographic characteristics. by Hea Ree Park (10769827)

Subjects:

Regression analysis of sleep habits and sleep-related symptoms associated with pandemic status. by Hea Ree Park (10769827)

Subjects:

Study flow chart. by Hea Ree Park (10769827)

Subjects:

Linear mixed-effect model determination of factors associated with changes in best-corrected visual acuity. by Jung-Tae Kim (8997767)

Subjects:

Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Subjects:

Subgroup analysis of Acute renal failure based on pump type. by Mohamed R. Abdelraouf (21501468)

Subjects:

Install base trends in Cameroon vs Ethiopia, Ghana and Kenya. by Henri Claude Moungui (22227043)

Subjects:

CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

Subjects:

Antibiotic Resistome Changes Associated with Different Types of Corrosion Inhibitors When Chlorine is Used as a Disinfectant by Lee K. Kimbell (21520910)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects: